Phil Taylor

The EMA and FDA jointly published 10 common principles for responsible AI use in pharmaceutical drug development, establishing a regulatory framework for AI adoption across the industry as biopharma companies rapidly accelerate AI partnerships.

“Author of "The Pharma Rulebook of AI"”